 CAMBRIDGE, Mass., July 22, 2021 GLOBE NEWSWIRE -- Evelo Biosciences Nasdaq:EVLO, a clinical stage biotechnology company developing a new modality of orally delivered medicines, today announced that it will host a conference call and live webcast at 8:30 a.m. ET on Thursday, July 29, 2021, to report its second quarter 2021 financial results and discuss business highlights. 